Clinical trial

Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The…

NCT00484718 · Pfizer, Industry · Terminated

Key facts

NCT number NCT00484718
Title Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib.
Official title MEASURES OF GAIT AND SELF-REPORTED PAIN IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE: A RANDOMIZED, SINGLE-BLIND WASHOUT, DOUBLE-BLIND TREATMENT, DOUBLE DUMMY CROSS-OVER PILOT TRIAL USING PLACEBO, OXYCODONE AND CELECOXIB (A9011030)
Lead sponsor Pfizer, Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Osteoarthritis
Intervention type Drug
Interventions celecoxib, Oxycodone, placebo
Enrollment 6
Start date Jan 17, 2008
Primary completion Jun 10, 2009
Completion Jun 10, 2009
First posted Jun 11, 2007
Last update posted Apr 14, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies